Literature DB >> 9640216

The use of complementary therapies by breast cancer patients attending conventional treatment.

E Crocetti1, N Crotti, A Feltrin, P Ponton, M Geddes, E Buiatti.   

Abstract

The aim of this study was to measure the proportion and characteristics of complementary therapy (CT) users among female breast cancer patients receiving conventional treatment. 473 women who had received surgical intervention for breast cancer in the year of diagnosis were sent a questionnaire for completion, and 242 responded. CT had been used by 16.5% after cancer diagnosis, only 8.7% before. The most commonly used CTs were homeopathy, manual healing method, herbalism and acupuncture. The main reason for using CTs was physical distress. Only a minority was searching for psychological support. 24 users were satisfied with these treatments, and two-thirds would suggest them. Users were significantly younger, more educated, and previous users of CTs than non-users. Adjusting each variable for the effect of the others, only previous use had an independent effect on increasing the probability of being users after cancer diagnosis.

Entities:  

Mesh:

Year:  1998        PMID: 9640216     DOI: 10.1016/s0959-8049(97)10043-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.

Authors:  Marion M Lee; Jeffrey S Chang; Bradly Jacobs; Margaret R Wrensch
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

3.  Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients.

Authors:  Kristen Arthur; Juan Carlos Belliard; Steven B Hardin; Kathryn Knecht; Chien-Shing Chen; Susanne Montgomery
Journal:  Integr Cancer Ther       Date:  2012-02-07       Impact factor: 3.279

4.  Predictors of yoga use among patients with breast cancer.

Authors:  Krupali Desai; Marjorie A Bowman; Mary Lou Galantino; Chanita Hughes-Halbert; Neha Vapiwala; Angela Demichele; Jun J Mao
Journal:  Explore (NY)       Date:  2010 Nov-Dec       Impact factor: 1.775

5.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Authors:  Aline Sarradon-Eck; Anne-Déborah Bouhnik; Dominique Rey; Marc-Karim Bendiane; Laetitia Huiart; Patrick Peretti-Watel
Journal:  J Cancer Surviv       Date:  2017-02-01       Impact factor: 4.442

6.  Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.

Authors:  Jing Wu; Coral Omene; Jerzy Karkoszka; Maarten Bosland; Jonathan Eckard; Catherine B Klein; Krystyna Frenkel
Journal:  Cancer Lett       Date:  2011-05-13       Impact factor: 8.679

7.  Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality.

Authors:  Eran Ben-Arye; Gil Bar-Sela; Moshe Frenkel; Abraham Kuten; Doron Hermoni
Journal:  Support Care Cancer       Date:  2005-08-16       Impact factor: 3.603

8.  Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action.

Authors:  Coral Omene; Matko Kalac; Jing Wu; Enrica Marchi; Krystyna Frenkel; Owen A O'Connor
Journal:  J Cancer Sci Ther       Date:  2013-10-21

Review 9.  Effective communication about the use of complementary and integrative medicine in cancer care.

Authors:  Moshe Frenkel; Lorenzo Cohen
Journal:  J Altern Complement Med       Date:  2013-07-17       Impact factor: 2.579

10.  Absent and Discordant Electronic Health Record Documentation of Complementary and Alternative Medicine in Cancer Care.

Authors:  Daniela L Stan; Dietlind L Wahner-Roedler; Kathleen J Yost; Thomas Jamie O'Byrne; Megan E Branda; Aaron L Leppin; Jon C Tilburt
Journal:  J Altern Complement Med       Date:  2018 Sep/Oct       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.